Trinity Biotech reported $137.98M in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Bayer EUR 36.45B 2.93B Dec/2025
Bio-Rad Laboratories USD 1.38B 7.9M Mar/2026
EDAP TMS EUR 27.79M 20.24M Mar/2026
J&J USD 54.99B 7.05B Mar/2026
Mesa Laboratories USD 204.98M 7.27M Sep/2024
OraSure Technologies USD 782K 465K Jun/2024
Plus Therapeutics USD 3.98M 372K Dec/2023
Roche Holding CHF 33.03B 1.41B Jun/2025
Siemens EUR 54.16B 2.3B Mar/2026
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
Tosoh JPY 228.91B 56.6B Mar/2026
Trinity Biotech USD 137.98M 37.22M Dec/2025
Veracyte USD 39.33M 321K Mar/2026